No treatment is available for most of these<unk> s. Mannose supplementation relieves the symptoms in MPI-CDG for the most part, even though the hepatic fibrosis may persist. Fucose supplementation has had a partial effect on some SLC35C1-CDG patients.
Congenital disorder of glycosylation
GM2 gangliosidoses
GM1 gangliosidoses
Mucopolysaccharidosis
Inborn errors of carbohydrate metabolism
Sphingolipidoses
Lysinuric protein intolerance
Infantile free sialic acid storage disease